FATE director Laura Hamill files initial Form 3

FATE Therapeutics Inc. director Laura Hamill has filed an initial Form 3, which is a required statement of beneficial ownership for insiders.

Rhea-AI Filing Summary

FATE Therapeutics Inc. director Laura Hamill has filed an initial Form 3, which is a required statement of beneficial ownership for insiders. The data provided shows no reported transactions or derivative positions, indicating this is an administrative disclosure of her insider status rather than a trading event.

Key Terms

Form 3, beneficial ownership, reporting person

3 terms

Form 3 regulatory

"Laura Hamill has filed an initial Form 3, which is a required statement of beneficial ownership"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

beneficial ownership financial

"Form 3, which is a required statement of beneficial ownership for insiders"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

reporting person regulatory

"The reporting person is Laura Hamill, identified as a director of FATE Therapeutics Inc."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Laura Hamill’s Form 3 filing for FATE Therapeutics (FATE) indicate?

Laura Hamill’s Form 3 indicates she is an insider of FATE Therapeutics as a director. It is an initial statement of beneficial ownership and, in this data, serves as an administrative disclosure rather than reflecting any recent trading activity.

Does Laura Hamill’s Form 3 for FATE show any share purchases or sales?

No, the summarized Form 3 data shows zero buy, sell, acquire, or dispose transactions. All transaction counters are listed as zero, meaning this filing does not report any recent trading activity in FATE Therapeutics shares by the reporting person.

What is the significance of transaction counts being zero in FATE’s Form 3?

All transaction counts being zero means the filing records no recent trades, gifts, exercises, or restructurings. It functions purely as an initial ownership statement, confirming insider status without signaling any change in position through market or non-market transactions.

Who is the reporting person on this FATE Therapeutics Form 3 filing?

The reporting person is Laura Hamill, identified as a director of FATE Therapeutics Inc. Her role classifies her as an insider under SEC rules, requiring disclosure of beneficial ownership through Form 3 and subsequent updates if she later reports transactions.

Does the Form 3 for FATE mention any derivative securities for Laura Hamill?

No, the derivative summary section for this Form 3 is empty, and the derivative transaction count is zero. This indicates that, in the data provided, there are no option, warrant, or other derivative positions reported for Laura Hamill at this time.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/15/2026 - 04:04 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Hamill Laura

(Last) (First) (Middle)

C/O FATE THERAPEUTICS, INC.

12278 SCRIPPS SUMMIT DRIVE

(Street)

SAN DIEGO CALIFORNIA 92131

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
06/12/2026

3. Issuer Name and Ticker or Trading Symbol
FATE THERAPEUTICS INC [ FATE ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Cindy Tahl, as Attorney-in-Fact	06/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)